News Daily News Impella RP Mortality Rate No Longer a Concern, FDA Says Caitlin E. Cox December 05, 2022
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for November 2022 Caitlin E. Cox December 01, 2022
News Daily News Many STEMI Patients Not Treated Within National Time Goals Michael O'Riordan November 15, 2022
News Conference News AHA 2022 Novel Intervention to Increase GDMT in HF Exploits Noncardiac Admissions Yael L. Maxwell November 01, 2022
News Daily News FDA: New Fix Available for Medtronic’s Troubled HeartWare VADs Michael O'Riordan October 17, 2022
News Conference News HFSA 2022 REDWOOD-HCM OLE: Aficamten Improves Patient-Measured Health Status L.A. McKeown October 07, 2022
News Daily News LivaNova Recalls Some LifeSPARC Controllers Used in Advanced Circulatory Support L.A. McKeown September 30, 2022
News Conference News TCT 2022 FLASH: More Data to Support Mechanical Thrombectomy in PE L.A. McKeown September 18, 2022
News Conference News TCT 2022 New Faces, New Formats, New Tech: What to Expect From TCT 2022 Shelley Wood September 07, 2022
News Daily News Monkeypox and the Heart: Acute Myocarditis Rare, With Good Outlook L.A. McKeown September 02, 2022
News Conference News ESC 2022 COVID-PACT: Full-Dose Anticoagulation Improves Outcomes in Critical COVID-19 Todd Neale September 01, 2022
News Conference News ESC 2022 PCI No Better Than GDMT in Ischemic Cardiomyopathy: REVIVED-BCIS2 Michael O'Riordan August 27, 2022
News Daily News Dobutamine Shortage: ACC Experts Offer Tips, Alternatives Shelley Wood August 11, 2022
News Daily News Lp(a) Levels Linked to Aortic Valve Calcification, Not Progression Michael O'Riordan August 08, 2022
News Daily News US Dobutamine Shortage a ‘Huge Problem’—What’s the Solution? Shelley Wood July 15, 2022
News Daily News Subclinical Thrombosis After TAVI Benign, at Least to 3 Years Michael O'Riordan June 07, 2022
News Daily News Timely PCI May Outweigh Hospital Factors for ACS Patients With Cardiogenic Shock Caitlin E. Cox April 18, 2022
News Conference News ACC 2022 New HF Guidelines Stress Four-Drug Approach, ‘HFmrEF,’ Amyloidosis Options, and More Shelley Wood April 01, 2022